Understanding attitudes towards psychiatric medications: a comparative study of patients, healthcare professionals, and general population perspectives.
{"title":"Understanding attitudes towards psychiatric medications: a comparative study of patients, healthcare professionals, and general population perspectives.","authors":"Seda Yavuz, Yavuz Yılmaz, Erdi Bahadır","doi":"10.1007/s00228-025-03879-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In recent years, with the increasing challenges in living conditions, there has been a rise in individuals seeking psychiatric support. This situation may lead to changes in attitudes and perceptions towards psychiatric medication treatments.</p><p><strong>Aim: </strong>This study aims to examine the attitudes of stable psychiatric patients, healthcare professionals, and the general population toward psychiatric medication treatments.</p><p><strong>Method: </strong>The study included 311 stable psychiatric patients, 200 healthcare professionals, and 274 participants from the general population. Participants were administered a data form that questioned sociodemographic and clinical characteristics, the Drug Attitude Inventory-10, and the Beliefs about Medicines Questionnaire.</p><p><strong>Results: </strong>The study reveals significant differences in attitudes towards medication among stable psychiatric patients, non-psychiatric healthcare professionals, and the general population. Stable psychiatric patients tend to have a stronger belief in the positive effects of medication and are more likely to internalize medications in their daily lives. However, this group experiences side effects more intensely compared to other groups. Healthcare professionals maintain a balanced stance regarding the benefits and side effects of medications, while the general population exhibits a more negative attitude towards medications and expresses greater concern about the addictive potential of these drugs.</p><p><strong>Conclusion: </strong>Considering these differences may contribute to more effective management of treatment processes and improve attitudes toward medications.</p>","PeriodicalId":11857,"journal":{"name":"European Journal of Clinical Pharmacology","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00228-025-03879-7","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: In recent years, with the increasing challenges in living conditions, there has been a rise in individuals seeking psychiatric support. This situation may lead to changes in attitudes and perceptions towards psychiatric medication treatments.
Aim: This study aims to examine the attitudes of stable psychiatric patients, healthcare professionals, and the general population toward psychiatric medication treatments.
Method: The study included 311 stable psychiatric patients, 200 healthcare professionals, and 274 participants from the general population. Participants were administered a data form that questioned sociodemographic and clinical characteristics, the Drug Attitude Inventory-10, and the Beliefs about Medicines Questionnaire.
Results: The study reveals significant differences in attitudes towards medication among stable psychiatric patients, non-psychiatric healthcare professionals, and the general population. Stable psychiatric patients tend to have a stronger belief in the positive effects of medication and are more likely to internalize medications in their daily lives. However, this group experiences side effects more intensely compared to other groups. Healthcare professionals maintain a balanced stance regarding the benefits and side effects of medications, while the general population exhibits a more negative attitude towards medications and expresses greater concern about the addictive potential of these drugs.
Conclusion: Considering these differences may contribute to more effective management of treatment processes and improve attitudes toward medications.
期刊介绍：
The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans. Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs. Methodological contributions relevant to these topics are also welcomed.
Data from animal experiments are accepted only in the context of original data in man reported in the same paper. EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants. Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor.
Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves
-a compound that is interesting and new in some basic or fundamental way, or
-methods that are original in some basic sense, or
-a highly unexpected outcome, or
-conclusions that are scientifically novel in some basic or fundamental sense.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
